Type
. Australia antigen (hepatitis-associated antigen). Australian and New Zealand journal of medicine. 1972;2(3):278-91.
Type
. Transfer of immune responsiveness. The Medical clinics of North America. 1972;56(2):465-80.
Type
. The management of the foot in leprosy. Clinical orthopaedics and related research. 1972;85:115-21.
Type
. [Physico-chemical, immunologic and epidemiologic aspects of the hepatitis associated antigen]. Sangre. 1972;17(1):1-24.
Type
. Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin. The American journal of tropical medicine and hygiene. 1971;20(4):616-20.
Type
. The severely deformed foot in leprosy. Causation, prevention and treatment. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(2):618-26.
Type
. Sequential blockade of the mycobacterial de novo folate pathway. A review. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1971;39(1):34-43.
Type
. Training of paramedical workers and their use in the leprosy program. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1970;38(4):433-5.
Type
. Leprosy in Ceylon. IMJ. Illinois medical journal. 1970;138(1):87-91.
Type
. [An unusual diagnosis in practitioner dermatology]. La Presse medicale. 1969;77(18):673.